Indium In-111 Pentetreotide and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Indium In-111 Pentetreotide and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetreotide in-111
Brand name: OctreoScan
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indium In-111 Pentetreotide-Insulin degludec
- Indium In-111 Pentetreotide-Insulin Degludec (U-100) Prefilled Pens
- Indium In-111 Pentetreotide-Insulin Degludec (U-100) Vials
- Indium In-111 Pentetreotide-Insulin Degludec (U-200) Prefilled Pens
- Indium In-111 Pentetreotide-Insulin degludec and liraglutide
- Indium In-111 Pentetreotide-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Indium Oxyquinoline
- Insulin aspart, recombinant Subcutaneous-Indocid
- Insulin aspart, recombinant Subcutaneous-Indocin
- Insulin aspart, recombinant Subcutaneous-Indocin (Indomethacin Suppositories)
- Insulin aspart, recombinant Subcutaneous-Indocin (Indomethacin Suspension)
- Insulin aspart, recombinant Subcutaneous-Indocin Injection